The Patent Finder
US

Selective Serotonin 2A/2C Receptor Inverse Agonists as Therapeutics for Neurodegenerative Diseases

US 7,732,462 In force
OverviewFamilyAssignmentsSources & methods

Term ends Dec 12, 2026 · High confidence

Filed May 3, 2006 as application 11/416,527 · Granted Jun 8, 2010
Base term plus 1062 days of patent term adjustment (USPTO delay)
Today
20 years from filing
2004 2026
Clock starts
Jan 15, 2004
Term ends
Dec 12, 2026
Granted
Jun 8, 2010
base term patent term adjustment fee events Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
1,062
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
14
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term runs 1062 days past its 20-year base term on prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Jan 15, 2004, when application 10/759,561, the earliest non-provisional in its chain, was filed (this one was filed May 3, 2006)Jan 15, 2024High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustment+1062 days, USPTO patent term adjustment recordDec 12, 2026High confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events3 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderDec 12, 2026High confidence

This family

US 7,601,740In force
Jan 2031
Jan 2031
US 7,732,462this patent
Dec 2026
Dec 2026
US 7,994,193Term ended
Jan 2024
Jan 2024
US 8,227,487Term ended
Jan 2024
Jan 2024
US 8,377,959Term ended
Jan 2024
Jan 2024
US 8,618,130Term ended
no later than Jan 2024
no later than Jan 2024
US 8,921,393Term ended
no later than Jan 2024
no later than Jan 2024
US 9,211,289Term ended
Jan 2024
Jan 2024
8 of 14 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Jul 15, 2008
Reel 21247, frame 176
Andersson, Carl-magnus A.; Uldam, Allan K.Acadia Pharmaceuticals, Inc.Assignment of Assignor's Interest
Jul 21, 2010
Reel 24719, frame 79
Weiner, David M.; Davis, Robert E.; Brann, Mark R.Acadia Pharmaceuticals Inc.Assignment of Assignor's Interest
Nov 30, 2021
Reel 58945, frame 485
Acadia Pharmaceuticals Inc.Acadia Pharmaceuticals Inc.Assignee Change of Address

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited